Skip to main content

GEODE CAPITAL MANAGEMENT, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1214717 BOSTON, MA

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$4,142,919,866
+$498,032,582 QoQ
Shares Held
29,726,052
+0.1% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.86236651944228.ToString("F0")% Shared 0.ToString("F0")% None 0.13763348055772762.ToString("F0")%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $67,874,952,284 across 14 Drug Manufacturers - General names. GILD ranks #6 (6.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 GILD
Gilead Sciences, Inc.
This page
29,726,052 $4,142,919,866

All Filings in GILD

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $4,142,919,866 29,726,052
2025-12-31 $3,644,887,284 29,696,002
2025-09-30 $3,322,117,446 29,928,986
2025-06-30 $3,238,253,485 29,207,662
2025-03-31 $3,191,200,470 28,480,147
2024-12-31 $2,613,139,632 28,289,917
2024-09-30 $2,309,026,540 27,540,870
2024-06-30 $1,850,168,065 26,966,449
2024-03-31 $1,930,090,253 26,349,355
2023-12-31 $2,047,461,726 25,274,185
2023-09-30 $1,850,691,186 24,695,639
2023-06-30 $1,866,067,856 24,212,636
2023-03-31 $1,971,786,281 23,765,051
2022-12-31 $2,047,391,750 23,848,477
2022-09-30 $1,456,105,528 23,603,591
2022-06-30 $1,432,296,860 23,172,575
2022-03-31 $1,349,733,003 22,703,667
2021-12-31 $1,651,091,787 22,739,179
2021-09-30 $1,557,549,107 22,298,484
2021-06-30 $1,509,089,004 21,915,321
2021-03-31 $1,335,986,506 20,671,306
2020-12-31 $1,169,797,878 20,078,920
2020-09-30 $1,263,924,989 20,001,978
2020-06-30 $1,513,058,568 19,665,435
2020-03-31 $1,486,416,297 19,882,508